FDA approved cannabis products schedule change

FDA Cannabis Products Move from Schedule I to Schedule III Under New DEA Rule

By Benjamin Caplan, MD

Comments Off on FDA Cannabis Products Move from Schedule I to Schedule III Under New DEA Rule

June 9, 2026

3 Min Read

The U.S. Department of Justice has proposed rescheduling FDA-approved cannabis-derived products from Schedule I to Schedule III, recognizing their medical utility while maintaining controlled substance oversight. This cannabis schedule III…